Dr Yo is convinced


From his twitter:

Quote:

---

Dr. Yo
@YoDoctorYo
·
51m
IMO: mild to moderate group is the TOUGHEST group to show significance. Most patients get better when looking at overall #COVID19 data- so any improvement is very impressive. Will await to see more data and values.
#cydy #leronlimab

57m
P2 trial looked at mild to moderate: keep in mind most of these patients were going to get better anyways. And still:
- strong p values
- faster improvement in viral symptoms in study arm v. SOC
- better safety profile than SOC

---